Epilepsy responds to cannabidiol, a medicine derived from marijuana, in more than half of patients, a new study reveals. Who could benefit from this finding?
Epilepsy responds to cannabidiol, a medicine derived from marijuana, in more than half of patients, a new study reveals. Who could benefit from this finding?